QR Pharma Has a Gut Feeling about Parkinson's Read more here
Read More
QR Pharma Awarded Funding by Michael J. Fox Foundation to Test Posiphen® as a Treatment for Parkinson's Disease Read more here
Read More
Ceptaris Secures $15M in Venture Debt Financing Read more here
Read More
Firm Logs Instant Feedback on Doctor Visits Read more here
Read More
CarePartners Plus® Launches Wellby® -- A New Innovative Patient Engagement and Feedback Technology Tool Read more here
Read More
Niiki Pharma Forms Scientific Advisory Board with Leading U.S. Oncologists Read more here
Read More
Ceptaris Therapeutics Receives EMA Orphan Drug Designation for Proprietary Mechlorethamine Gel Read more here
Read More
Niiki Pharma Announces the Completion of Phase I Dose Escalation for First-in-Man Anti-Cancer Agent NKP-1339 Read more here
Read More
Niiki Pharma Developing New Weapons to Battle Cancer Read more here
Read More
Yaupon Changes Name to Ceptaris Therapeutics, Inc. Read more here
Read More
Ossianix Announces Lundbeck Investment Read more here
Read More
FDA Permits Marketing of the First Hand-held Device to Aid in the Detection of Bleeding in the Skull
FDA Permits Marketing of the First Hand-held Device to Aid in the Detection of Bleeding in the Skull Read more here
Read More
InfraScan Inc. Announces Issuance of US Patent for Hematoma Detection Read more here
Read More
Galleon Pharmaceuticals Names Lynne Brookes Senior Vice President and Chief Business Officer Read more here
Read More
Niiki Pharma Reports on Synergistic Activity of Novel Anti-Cancer Agent NKP-1339 with Other Anti-Cancer Agents Read more here
Read More
BioAdvance Names Sam Katz as Chair and Elects J. Larry Jameson, M.D., Ph.D., and Lauren Lenfest as Directors Read more here
Read More
QR Pharma, Inc. CEO Awarded Iris Newman Women Entrepreneur of the Year Read more here
Read More
QR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models Read more here
Read More
FDA Accepts Filing of New Drug Application (NDA) for Yaupon's Proprietary Gel Formulation of Mechlorethamine Hydrochloride Read more here
Read More